Pages that link to "Q59679318"
Jump to navigation
Jump to search
The following pages link to Pilar Blancafort (Q59679318):
Displaying 50 items.
- Suppression of breast tumor growth and metastasis by an engineered transcription factor (Q21135222) (← links)
- Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors (Q24605597) (← links)
- Epigenome engineering in cancer: fairytale or a realistic path to the clinic? (Q26861350) (← links)
- Development of zinc finger domains for recognition of the 5'-CNN-3' family DNA sequences and their use in the construction of artificial transcription factors (Q28267768) (← links)
- The recognition of a noncanonical RNA base pair by a zinc finger protein. (Q30743216) (← links)
- Scanning the human genome with combinatorial transcription factor libraries. (Q30887293) (← links)
- In vivo selection of combinatorial libraries and designed affinity maturation of polydactyl zinc finger transcription factors for ICAM-1 provides new insights into gene regulation (Q31103838) (← links)
- Promoter-targeted phage display selections with preassembled synthetic zinc finger libraries for endogenous gene regulation. (Q33204106) (← links)
- Genetic reprogramming of tumor cells by zinc finger transcription factors (Q33221141) (← links)
- Modulation of drug resistance by artificial transcription factors. (Q33322421) (← links)
- Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation (Q34249565) (← links)
- Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function. (Q34285190) (← links)
- Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules (Q34476349) (← links)
- Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor. (Q35563726) (← links)
- Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor. (Q35683564) (← links)
- Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs) (Q35754831) (← links)
- Designing transcription factor architectures for drug discovery. (Q35875911) (← links)
- Gene expression in breastmilk cells is associated with maternal and infant characteristics. (Q35974781) (← links)
- The CRISPR road: from bench to bedside on an RNA-guided path. (Q35976998) (← links)
- Epigenetic reprogramming of cancer cells via targeted DNA methylation. (Q36012682) (← links)
- Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer (Q36144913) (← links)
- Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer (Q36249272) (← links)
- Sequence-specific biosensors report drug-induced changes in epigenetic silencing in living cells. (Q36286672) (← links)
- Breastmilk is a novel source of stem cells with multilineage differentiation potential. (Q36310036) (← links)
- Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factors. (Q36669986) (← links)
- Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy (Q36673747) (← links)
- Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation (Q36675328) (← links)
- Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary Gland (Q36756450) (← links)
- Cisplatin induces differentiation of breast cancer cells (Q36893886) (← links)
- Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system (Q37645061) (← links)
- Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA. (Q37733938) (← links)
- Long live the stem cell: the use of stem cells isolated from post mortem tissues for translational strategies (Q38258619) (← links)
- Evaluation of a modular strategy for the construction of novel polydactyl zinc finger DNA-binding proteins (Q38357603) (← links)
- Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide. (Q38777346) (← links)
- Remodeling genomes with artificial transcription factors (ATFs). (Q39672306) (← links)
- Hallmarks of cancer: The CRISPR generation (Q50059665) (← links)
- Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells (Q50117674) (← links)
- Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing. (Q52430722) (← links)
- Non-viral Methodology for Efficient Co-transfection. (Q52430732) (← links)
- Atomistic molecular dynamics simulations of bioactive engrailed 1 interference peptides (EN1-iPeps). (Q55364585) (← links)
- Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells (Q57059036) (← links)
- Frequent lack of repressive capacity of promoter DNA methylation identified through genome-wide epigenomic manipulation (Q57634834) (← links)
- PolI-driven integrative expression vectors for yeast (Q73563833) (← links)
- Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors (Q79290471) (← links)
- Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers (Q90535138) (← links)
- Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers (Q90748016) (← links)
- Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics (Q90859674) (← links)
- Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System (Q91092221) (← links)
- Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides (Q91760669) (← links)
- Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer (Q99408079) (← links)